Naloxone Hydrochloride Injection
Product Images NDC 71872-7294

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 71872-7294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7294.jpg (7294)

7294.jpg (7294)
This is a description of Naloxone Hydrochloride Inj., a medication that comes in a prefilled syringe to be used as an opiod antagonist for intravenous, intramuscular or subcutaneous use. The medication is a single-dose, and the syringe is disposable and non-reusable. It is made up of naloxona hydochloride and sodium chloride in 2mg per 2mL of liquid. The medication is fluid pathway sterile and non-pyrogenic in a package with component caps in place. The usual dosage instructions can be found in the provided insert. This medication is manufactured for International Mediation Systems, Limited and is for Injection, Intravenous, Intramuscular or Subcutaneous use. The lot number is X0X-)000C and it expires on XXPOOK.*
FDA Label Image

Instructure (Instructions)

Instructure (Instructions)
This text provides instructions for using an injector with a vial. It advises the user to remove the protective caps before aligning the vial for injection. The vial should be threaded into the injector for three half turns until the needle penetrates the stopper. The user should then expel air before injecting but should be careful not to push the vial into the injector to avoid misalignment.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.